Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA.

ChongFeng GaoLuke WisniewskiYing LiuBen StaalIan BeddowsDennis PlenkerMohammed AldakkakJohnathan HallDaniel BarnettMirna Kheir GoudaPeter AllenRichard DrakeAmer ZureikatYing Huang Douglas B EvansAatur SinghiRandall E BrandDavid A TuvesonSusan TsaiBrian B Haab

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

This research demonstrates that a glycan biomarker could have value to detect chemotherapy-resistant PDAC in clinical settings. This capability could aid in the development of stratified treatment plans and facilitate biomarker-guided trials targeting resistant PDAC.

Keyphrases

locally advanced
cell surface
health insurance
radiation therapy
cancer therapy
combination therapy
real time pcr
label free
quantum dots